Business description: Carmat

Sales by Activity: Carmat
| Fiscal Period: December | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|
Medical Products | 9.33K | 2.24M | 477K | 3.84M | 7.34M |
Geographical breakdown of sales: Carmat
| Fiscal Period: December | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|
Export | - | 2.23M | 205K | 1.47M | 3.59M |
France | 9.33K | - | 140K | 1.33M | 3.38M |
Unallocated | - | 8K | 132K | 1.04M | 375K |
Executive Committee: Carmat
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Piat
CEO | Chief Executive Officer | 55 | 2016-08-31 |
| Director of Finance/CFO | - | 2018-12-11 | |
| Chief Tech/Sci/R&D Officer | - | 2025-03-31 | |
Marc Grimmé
CTO | Chief Tech/Sci/R&D Officer | - | 2009-11-30 |
| Corporate Officer/Principal | - | - |
Composition of the Board of Directors: Carmat
| Director | Title | Age | Since |
|---|---|---|---|
Stéphane Piat
BRD | Director/Board Member | 55 | - |
| Director/Board Member | 68 | 2017-01-01 | |
Michael Mack
BRD | Director/Board Member | 79 | 2017-04-19 |
Pierre Bastid
CHM | Chairman | 71 | 2024-06-24 |
| Director/Board Member | 63 | 2021-05-06 | |
David Coti
BRD | Director/Board Member | 41 | 2021-05-06 |
John Hernandez
BRD | Director/Board Member | 59 | 2021-05-06 |
| Director/Board Member | 64 | 2022-12-31 | |
Paolo Rampulla
BRD | Director/Board Member | 54 | 2022-12-31 |
Laurent Kirsch
BRD | Director/Board Member | 58 | 2023-03-10 |
Company details: Carmat

Medical Devices & Implants
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.54% | +3.25% | -18.16% | +13.52% | 127B | ||
| +1.92% | -0.96% | -2.85% | -4.52% | 12.79B | ||
| +0.95% | -2.07% | +62.86% | +106.79% | 9.02B | ||
| -6.12% | -1.94% | -48.53% | -70.40% | 4.39B | ||
| -0.21% | -2.71% | -1.65% | +36.76% | 2.63B | ||
| -2.59% | -0.76% | -20.35% | -25.38% | 1.59B | ||
| -3.05% | -2.46% | -27.45% | -34.57% | 1.58B | ||
| +3.72% | -0.15% | -1.85% | -57.71% | 1.56B | ||
| Average | -0.23% | -1.82% | -7.25% | -4.44% | 20.02B | |
| Weighted average by Cap. | +2.81% | +2.14% | -12.89% | +13.86% |

















